S. Oi et al. / Tetrahedron: Asymmetry 17 (2006) 598–602
601
4.3.9. 3-(4-Methoxyphenyl)butanoic acid isopropyl ester
3cb.6d 1H NMR (500 MHz, CDCl3) d 7.13 (d,
J = 9 Hz, 2H), 6.83 (d, J = 9 Hz, 2H), 4.99 (sept,
J = 6.3 Hz, 1H), 3.77 (s, 3H), 3.22 (sext, J = 7.1 Hz),
2.53 (dd, J = 14.5, 7.3 Hz, 1H), 2.48 (dd, J = 14.5,
7.5 Hz, 1H), 1.27 (d, J = 7 Hz, 3H), 1.17 (d,
J = 6.5 Hz, 3H), 1.12 (d, J = 6.3 Hz, 3H). 13C NMR
4.3.15. N-Benzyl-3-(4-Methoxyphenyl)butyramide 5eb.6g
1H NMR (500 MHz, CDCl3) d 7.26–7.22 (m, 3H), 7.15–
7.12 (m, 2H), 7.02–7.00 (m, 2H), 6.85–6.80 (m, 2H), 5.49
(s, 1H), 4.38 (dd, J = 14.5, 6.3 Hz, 1H), 4.27 (dd,
J = 14.5, 5.4 Hz, 1H), 3.78 (s, 3H), 3.28 (sext,
J = 7.5 Hz, 1H), 2.45 (dd, J = 13.5, 6.5 Hz, 1H), 2.39
(dd, J = 13.5, 8.3 Hz, 1H), 1.30 (d, J = 7 Hz, 3H). 13C
NMR (125 MHz, CDCl3) d 171.5, 158.2, 138.1, 127.8,
(125 MHz, CDCl3) d 171.9, 158.0, 137.8, 127.7, 113.7,
23
67.4, 55.2, 43.5, 35.8, 22.0, 21.7, 21.7. ½aꢀD ¼ ꢁ25 (c
20
128.5, 127.7, 127.6, 127.3, 114.0, 55.2, 46.2, 43.4, 36.3,
24
0.96, CHCl3) 88% ee {lit.6d ½aꢀD ¼ ꢁ21:6 (c 0.99, CHCl3)
22.0. ½aꢀD ¼ ꢁ3:3 (c 1.04, CDCl3) 90% ee (lit.6g
20
92% ee}.
½aꢀD ¼ ꢁ11:6 (c 1.00, CDCl3) 87% ee).
4.3.10. 3-(4-Chlorophenyl)butanoic acid isopropyl ester
3cc. 1H NMR (400 MHz, CDCl3) d 7.27–7.23 (m, 2H),
7.17–7.13 (m, 2H), 4.93 (sept, J = 7.5 Hz, 1H), 3.24
(sext, J = 7.2 Hz, 1H), 2.53 (dd, J = 14.8, 7.6 Hz, 1H),
2.49 (dd, J = 14.8, 7.6 Hz, 1H), 1.26 (d, J = 7 Hz, 3H),
1.16 (dd, J = 6.2 Hz, 3H), 1.11 (dd, J = 6.2 Hz, 3H).
13C NMR (100 MHz, CDCl3) d 171.5, 144.1, 131.8,
128.5, 128.1, 67.6, 43.0, 36.0, 21.8, 21.7, 21.6. IR (neat)
4.3.16. N-Benzyl-3-(4-Chlorophenyl)butyramide 5ec.
1H NMR (400 MHz, CDCl3) d 7.30–7.22 (m, 5H),
7.15–7.12 (m, 2H), 7.02–6.98 (m, 2H), 5.61 (s, 1H),
4.40 (dd, J = 14.8, 6.4H, 1H), 4.23 (dd, J = 14.8,
5.2 Hz, 1H), 3.32 (sext, J = 8 Hz, 1H), 2.45 (dd,
J = 14, 6.8 Hz, 1H), 2.37 (dd, J = 14, 8.3 Hz, 1H), 1.29
(d, J = 7 Hz, 3H). 13C NMR (100 MHz, CDCl3) d
171.0, 144.1, 128.0, 132.1, 128.7, 128.6, 128.2, 127.5,
127.4, 45.7, 43.4, 36.5, 21.7. IR (KBr) 3309, 3081,
1730, 1261, 1108, 1013 cmꢁ1
.
Anal. Calcd for
C13H17O2Cl: C, 64.86; H, 7.12; Cl, 14.73. Found: C,
1644, 1552, 1495, 1252 cmꢁ1
C17H18NOCl: C, 70.95; H, 6.30; N, 4.87; Cl, 12.32.
.
Anal. Calcd for
23
64.60; H, 6.94; Cl, 14.60. ½aꢀD ¼ ꢁ26 (c 1.02, CHCl3)
24
93% ee.
Found: C, 70.89; H, 6.51; N, 4.73; Cl, 12.18. ½aꢀD
¼
ꢁ8:8 (c 0.99, CDCl3) 92% ee.
4.3.11.
3-Phenylbutyramide
5aa.6g 1H
NMR
(500 MHz, CDCl3) d 7.41–7.19 (m, 5H), 5.67 (s, 1H),
5.37 (s, 1H), 3.27 (sext, J = 7.1 Hz, 1H), 2.53–2.40 (m,
2H), 1.32 (d, J = 7.0 Hz, 3H). 13C NMR (125 MHz,
Acknowledgement
CDCl3) d 174.2, 145.7, 128.6, 126.7, 126.5, 44.7, 36.7,
This work was partly supported by a Grant-in-Aid
for Scientific Research from the Ministry of Education,
Culture, Sports, Science and Technology, Japan.
24
21.7. ½aꢀD ¼ ꢁ36 (c 1.01, CHCl3) 81% ee (R) {lit.6g
20
½aꢀD ¼ ꢁ30:9 (c 1.01, CHCl3) 89% ee (R)}.
4.3.12. 3-Phenylhexanamide 5ba. 1H NMR (400 MHz,
CDCl3) d 7.32–7.18 (m, 5H), 5.52 (s, 1H), 5.26 (s, 1H),
3.12–3.04 (m, 1H), 2.51 (dd, J = 14.3, 6.6 Hz, 1H),
2.44 (dd, J = 14.3, 8.4 Hz, 1H), 1.71–1.54 (m, 2H),
1.25–1.10 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H). 13C
References
1. Knight, D. W. In Comprehensive Organic Synthesis; Trost,
B. M., Fleming, I., Eds.; Pergamon Press: Oxford, 1991;
Vol. 3, pp 481–520.
2. Review: Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56,
8033.
NMR (100 MHz, CDCl3)
127.4, 126.5, 43.8, 42.4, 38.4, 20.5, 13.9. IR (KBr)
3408, 3196, 1655, 1406 cmꢁ1
Anal. Calcd for
d 174.2, 144.2, 128.5,
.
C12H17NO: C, 75.35; H, 8.96; N, 7.32. Found: C,
3. Sakai, M.; Hayashi, H.; Miyaura, N. Organometallics
1997, 16, 4229.
24
75.16; H, 9.05; N, 7.16. ½aꢀD ¼ ꢁ29 (c 1.00, CHCl3)
4. Takaya, Y.; Ogasawara, M.; Hayashi, T.; Sakai, M.;
Miyaura, N. J. Am. Chem. Soc. 1998, 120, 5579.
5. Reviews: (a) Hayashi, T. Synlett 2001, 879; (b) Fagnou,
K.; Lautens, M. Chem. Rev. 2003, 103, 169; (c) Hayashi,
T.; Yamasaki, K. Chem. Rev. 2003, 103, 2829; (d)
Hayashi, T. Bull. Chem. Soc. Jpn. 2004, 77, 13; (e)
Hayashi, T. Pure Appl. Chem. 2004, 76, 465.
91% ee.
4.3.13. N,N-Dimethyl-3-phenylbutyramide 5da.33 1H
NMR (400 MHz, CDCl3) d 7.31–7.17 (m, 5H), 3.36
(sext, J = 6.9 Hz, 1H), 2.90 (s, 3H), 2.86 (s, 3H), 2.61
(dd, J = 15, 6.2 Hz, 1H), 2.51 (dd, J = 15, 8 Hz, 1H),
1.33 (d, J = 6.9 Hz, 3H). 13C NMR (100 MHz, CDCl3)
6. (a) Takaya, Y.; Senda, T.; Kurushima, H.; Ogasawara,
M.; Hayashi, T. Tetrahedron: Asymmetry 1999, 10, 4047;
(b) Takaya, Y.; Ogasawara, M.; Hayashi, T. Tetrahedron
Lett. 1999, 40, 6957; (c) Hayashi, T.; Senda, T.; Takaya,
Y.; Ogasawara, M. J. Am. Chem. Soc. 1999, 121, 11591;
(d) Sakuma, S.; Sakai, M.; Itooka, R.; Miyaura, N. J.
Org. Chem. 2000, 65, 5951; (e) Hayashi, T.; Senda, T.;
Ogasawara, M. J. Am. Chem. Soc. 2000, 122, 10716; (f)
Senda, T.; Ogasawara, M.; Hayashi, T. J. Org. Chem.
2001, 66, 6852; (g) Sakuma, S.; Miyaura, N. J. Org.
Chem. 2001, 66, 8944; (h) Kuriyama, M.; Tomioka, K.
Tetrahedron Lett. 2001, 42, 921; (i) Reetz, M. T.; Moulin,
D.; Gosberg, A. Org. Lett. 2001, 3, 4083; (j) Hayashi, T.;
Takahashi, M.; Takaya, Y.; Ogasawara, M. J. Am.
Chem. Soc. 2002, 124, 5052; (k) Kuriyama, M.; Nagai,
d 171.7, 146.5, 128.3, 126.8, 126.1, 41.7, 37.2, 36.4,
21
35.3, 21.5. ½aꢀD ¼ ꢁ16 (c 1.02, CHCl3) 72% ee (R)
25
(lit.33 ½aꢀD ¼ þ40:1 (c 4.66, EtOH) (S)).
4.3.14. N-Benzyl-3-phenylbutyramide 5ea.6g 1H NMR
(500 MHz, CDCl3) d 7.29–7.19 (m, 8H), 7.02–7.00 (m,
2H), 5.64 (s, 1H), 4.35 (dd, J = 14.8, 6 Hz, 1H), 4.26
(dd, J = 14.8, 5.5 Hz, 1H), 3.32 (sext, J = 7.1 Hz, 1H),
2.45 (d, J = 7.6 Hz, 2H), 1.31 (d, J = 7.1 Hz, 3H). 13C
NMR (125 MHz, CDCl3) d 171.4, 145.7, 138.1, 128.6,
128.5, 127.5, 127.3, 126.8, 126.4, 45.8, 43.4, 37.0, 21.8.
20
20
½aꢀD ¼ ꢁ13 (c 1.01, CDCl3) 92% ee (lit.6g ½aꢀD ¼ ꢁ12:1
(c 1.00, CDCl3) 93% ee).